Breadcrumbs Navigation

Home > News & Publications > News and Communications > News

Latest Health News from Duke Medicine News and Communications

 « Previous 10 Page of 31 Next 10 »

$15 Million Award to Go Toward Exploring New Treatments for Autism, Other Brain Disorders

Duke Medicine has been awarded $15 million to support an innovative research program that explores the use of umbilical cord blood cells to treat autism, stroke, cerebral palsy and related brain disorders.

Combining Treatments Boosts Some Smokers’ Ability to Quit

Combining two smoking cessation therapies is more effective than using just one for male and highly nicotine-dependent smokers who weren't initially helped by the nicotine patch, according to researchers at Duke Medicine.

Heparin Derivative Suppresses Neuroblastoma Tumor Growth

Researchers at Duke Medicine have identified a new strategy for treating neuroblastoma using a modified version of heparin, a century-old injectable drug that thins the blood to prevent clots from forming.

Lifetime Cancer Risk from Heart Imaging Low for Most Children, but Rises with More Complex Tests

Children with heart disease are exposed to low levels of radiation during X-rays, which do not significantly raise their lifetime cancer risk. However, children who undergo repeated complex imaging tests that deliver higher doses of radiation may have a slightly increased lifetime risk of cancer, according to researchers at Duke Medicine.

New Diagnostic Imaging Techniques Deemed Safe in Simulations

Gamma and neutron imaging offer possible improvements over existing techniques such as X-ray or CT, but their safety is not yet fully understood. Using computer simulations, imaging the liver and breast with gamma or neutron radiation was found to be safe, delivering levels of radiation on par with conventional medical imaging, according to researchers at Duke Medicine.

Registry for Fatal Lung Disease Aims to Speed Improvements in Care

Duke Clinical Research Institute (DCRI) has launched a patient registry to help researchers and clinicians identify, manage and study people who have a progressive lung disease called idiopathic pulmonary fibrosis.

One and Done: New Antibiotic Could Provide Single-Dose Option

In the battle against stubborn skin infections, including methicillin-resistant Staphylococcus aureus (MRSA), a new single-dose antibiotic is as effective as a twice-daily infusion given for up to 10 days, according to a large study led by Duke Medicine researchers.

Implanted Heart Device Linked to Increased Survival

Implantable cardioverter defibrillators (ICDs) are associated with improved survival among heart failure patients whose left ventricles only pump 30 to 35 percent of blood out of the heart with each contraction, according to a study from the Duke Clinical Research Institute.

Prostate cancer drug delivers benefits before chemotherapy

A drug currently used to treat men with late-stage prostate cancer proved effective in stemming disease progression and extending survival in patients who had not yet received chemotherapy, according to results from a large international study that included Duke Cancer Institute researchers.

Newly Identified Brain Cancer Mutation Will Aid Drug Development

A collaborative effort between Duke Medicine researchers and neurosurgeons and scientists in China has produced new genetic insights into a rare and deadly form of childhood and young adult brain cancer called brainstem glioma.

 « Previous 10 Page of 31 Next 10 »